CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 691 of 865
Non-Antibody Products
Page 691 of 865
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| 4-Quinolone-3-Carboxamide CB2 Ligand | A selective, high-affinity ligand of the CB2 receptor (Ki = 0.6 nM v. CB1… | 1 mg | 11093-1 | More Info |
| 4-Quinolone-3-Carboxamide CB2 Ligand | A selective, high-affinity ligand of the CB2 receptor (Ki = 0.6 nM v. CB1… | 10 mg | 11093-10 | More Info |
| 4-Quinolone-3-Carboxamide CB2 Ligand | A selective, high-affinity ligand of the CB2 receptor (Ki = 0.6 nM v. CB1… | 25 mg | 11093-25 | More Info |
| 4-Quinolone-3-Carboxamide CB2 Ligand | A selective, high-affinity ligand of the CB2 receptor (Ki = 0.6 nM v. CB1… | 5 mg | 11093-5 | More Info |
| 4-Quinolone-3-Carboxamide Furan CB2 Agonist | A high-affinity ligand of CB2 (Ki = 8.5 nM) with little affinity for CB1 (… | 1 mg | 11094-1 | More Info |
| 4-Quinolone-3-Carboxamide Furan CB2 Agonist | A high-affinity ligand of CB2 (Ki = 8.5 nM) with little affinity for CB1 (… | 10 mg | 11094-10 | More Info |
| 4-Quinolone-3-Carboxamide Furan CB2 Agonist | A high-affinity ligand of CB2 (Ki = 8.5 nM) with little affinity for CB1 (… | 25 mg | 11094-25 | More Info |
| 4-Quinolone-3-Carboxamide Furan CB2 Agonist | A high-affinity ligand of CB2 (Ki = 8.5 nM) with little affinity for CB1 (… | 5 mg | 11094-5 | More Info |
| Quin-2 (potassium salt) | A high-affinity fluorescent calcium indicator (Kd = 115 nM for calcium) th… | 5 mg | 20421-5 | More Info |
| Quinupristin (mesylate) | A streptogramin antibiotic that is usually combined with another streptogr… | 1 mg | 19764-1 | More Info |
| Quinupristin (mesylate) | A streptogramin antibiotic that is usually combined with another streptogr… | 5 mg | 19764-5 | More Info |
| Quizartinib | A selective FLT3 inhibitor (Kd = 1.6 nM) that inhibits the proliferation o… | 1 mg | 17986-1 | More Info |
| Quizartinib | A selective FLT3 inhibitor (Kd = 1.6 nM) that inhibits the proliferation o… | 10 mg | 17986-10 | More Info |
| Quizartinib | A selective FLT3 inhibitor (Kd = 1.6 nM) that inhibits the proliferation o… | 5 mg | 17986-5 | More Info |
| Quizartinib | A selective FLT3 inhibitor (Kd = 1.6 nM) that inhibits the proliferation o… | 500 µg | 17986-500 | More Info |
| Q-VD-OPH | A broad-spectrum caspase inhibitor, blocking caspases-3, -7, -8, -9, -10,… | 1 mg | 15260-1 | More Info |
| Q-VD-OPH | A broad-spectrum caspase inhibitor, blocking caspases-3, -7, -8, -9, -10,… | 5 mg | 15260-5 | More Info |
| QX-77 | An activator of chaperone-mediated autophagy; decreases paraquat- or oleic… | 10 mg | 29903-10 | More Info |
| QX-77 | An activator of chaperone-mediated autophagy; decreases paraquat- or oleic… | 25 mg | 29903-25 | More Info |
| QX-77 | An activator of chaperone-mediated autophagy; decreases paraquat- or oleic… | 5 mg | 29903-5 | More Info |
| QX-77 | An activator of chaperone-mediated autophagy; decreases paraquat- or oleic… | 50 mg | 29903-50 | More Info |
| QX-314 (bromide) | A membrane-impermeant lidocaine derivative that when combined with capsaic… | 100 mg | 10011032-100 | More Info |
| QX-314 (bromide) | A membrane-impermeant lidocaine derivative that when combined with capsaic… | 25 mg | 10011032-25 | More Info |
| QX-314 (bromide) | A membrane-impermeant lidocaine derivative that when combined with capsaic… | 50 mg | 10011032-50 | More Info |
| QX-314 (chloride) | A membrane-impermeant lidocaine derivative that when combined with capsaic… | 50 mg | 18454-50 | More Info |
| R 1530 | A multi-kinase inhibitor that targets over 20 kinases, including angiogene… | 1 mg | 15255-1 | More Info |
| R 1530 | A multi-kinase inhibitor that targets over 20 kinases, including angiogene… | 10 mg | 15255-10 | More Info |
| R 1530 | A multi-kinase inhibitor that targets over 20 kinases, including angiogene… | 25 mg | 15255-25 | More Info |
| R 1530 | A multi-kinase inhibitor that targets over 20 kinases, including angiogene… | 5 mg | 15255-5 | More Info |
| R112 | A Syk inhibitor (IC50 = 226 nM in cultured human mast cells); acts in an A… | 1 mg | 22929-1 | More Info |
| R112 | A Syk inhibitor (IC50 = 226 nM in cultured human mast cells); acts in an A… | 10 mg | 22929-10 | More Info |
| R112 | A Syk inhibitor (IC50 = 226 nM in cultured human mast cells); acts in an A… | 25 mg | 22929-25 | More Info |
| R112 | A Syk inhibitor (IC50 = 226 nM in cultured human mast cells); acts in an A… | 5 mg | 22929-5 | More Info |
| R162 | A GDH1 inhibitor (IC50 = 23 µM); decreases intracellular fumarate le… | 10 mg | 30922-10 | More Info |
| R162 | A GDH1 inhibitor (IC50 = 23 µM); decreases intracellular fumarate le… | 25 mg | 30922-25 | More Info |
| R162 | A GDH1 inhibitor (IC50 = 23 µM); decreases intracellular fumarate le… | 5 mg | 30922-5 | More Info |
| R162 | A GDH1 inhibitor (IC50 = 23 µM); decreases intracellular fumarate le… | 50 mg | 30922-50 | More Info |
| R-268712 | An inhibitor of ALK5 (IC50 = 2.5 nM); selective for ALK5 over p38 MAPK (IC… | 10 mg | 36810-10 | More Info |
| R-268712 | An inhibitor of ALK5 (IC50 = 2.5 nM); selective for ALK5 over p38 MAPK (IC… | 100 mg | 36810-100 | More Info |
| R-268712 | An inhibitor of ALK5 (IC50 = 2.5 nM); selective for ALK5 over p38 MAPK (IC… | 5 mg | 36810-5 | More Info |
| R-268712 | An inhibitor of ALK5 (IC50 = 2.5 nM); selective for ALK5 over p38 MAPK (IC… | 50 mg | 36810-50 | More Info |
| R406 | A potent orally available inhibitor of Syk (Ki = 30 nM); blocks Fc&epsilon… | 1 mg | 11422-1 | More Info |
| R406 | A potent orally available inhibitor of Syk (Ki = 30 nM); blocks Fc&epsilon… | 10 mg | 11422-10 | More Info |
| R406 | A potent orally available inhibitor of Syk (Ki = 30 nM); blocks Fc&epsilon… | 25 mg | 11422-25 | More Info |
| R406 | A potent orally available inhibitor of Syk (Ki = 30 nM); blocks Fc&epsilon… | 5 mg | 11422-5 | More Info |
| R428 | An inhibitor of Axl kinase (EC50 = 14 nM); orally bioavailable, blocks ang… | 1 mg | 21523-1 | More Info |
| R428 | An inhibitor of Axl kinase (EC50 = 14 nM); orally bioavailable, blocks ang… | 10 mg | 21523-10 | More Info |
| R428 | An inhibitor of Axl kinase (EC50 = 14 nM); orally bioavailable, blocks ang… | 25 mg | 21523-25 | More Info |
| R547 | An inhibitor of the cyclin-dependent kinases Cdk1 / cyclin B, Cdk2 / cycli… | 1 mg | 17905-1 | More Info |
| R547 | An inhibitor of the cyclin-dependent kinases Cdk1 / cyclin B, Cdk2 / cycli… | 5 mg | 17905-5 | More Info |
| R-568 | A calcimimetic and positive allosteric modulator of CaSR; potentiates extr… | 1 mg | 17415-1 | More Info |
| R-568 | A calcimimetic and positive allosteric modulator of CaSR; potentiates extr… | 10 mg | 17415-10 | More Info |
| R-568 | A calcimimetic and positive allosteric modulator of CaSR; potentiates extr… | 5 mg | 17415-5 | More Info |
| R-568 | A calcimimetic and positive allosteric modulator of CaSR; potentiates extr… | 50 mg | 17415-50 | More Info |
| R-59-022 | An inhibitor of DGK (IC50 = 2.8 µM), increasing DAG-dependent PKC ac… | 1 mg | 16772-1 | More Info |
| R-59-022 | An inhibitor of DGK (IC50 = 2.8 µM), increasing DAG-dependent PKC ac… | 10 mg | 16772-10 | More Info |
| R-59-022 | An inhibitor of DGK (IC50 = 2.8 µM), increasing DAG-dependent PKC ac… | 5 mg | 16772-5 | More Info |
| R-59-022 | An inhibitor of DGK (IC50 = 2.8 µM), increasing DAG-dependent PKC ac… | 50 mg | 16772-50 | More Info |
| R-59-949 | A DGK-α inhibitor (IC50 = 300 nM in isolated platelet plasma membran… | 1 mg | 21221-1 | More Info |
| R-59-949 | A DGK-α inhibitor (IC50 = 300 nM in isolated platelet plasma membran… | 10 mg | 21221-10 | More Info |
| R-59-949 | A DGK-α inhibitor (IC50 = 300 nM in isolated platelet plasma membran… | 25 mg | 21221-25 | More Info |
| R-59-949 | A DGK-α inhibitor (IC50 = 300 nM in isolated platelet plasma membran… | 5 mg | 21221-5 | More Info |
| R-7050 | A cell-permeable antagonist of signaling through the TNF-α receptor… | 1 mg | 16870-1 | More Info |
| R-7050 | A cell-permeable antagonist of signaling through the TNF-α receptor… | 10 mg | 16870-10 | More Info |
| R-7050 | A cell-permeable antagonist of signaling through the TNF-α receptor… | 25 mg | 16870-25 | More Info |
| R-7050 | A cell-permeable antagonist of signaling through the TNF-α receptor… | 5 mg | 16870-5 | More Info |
| R-848 | An immune response modifier that acts as a ligand of TLR7 and 8; demonstra… | 10 mg | 14806-10 | More Info |
| R-848 | An immune response modifier that acts as a ligand of TLR7 and 8; demonstra… | 25 mg | 14806-25 | More Info |
| R-848 | An immune response modifier that acts as a ligand of TLR7 and 8; demonstra… | 5 mg | 14806-5 | More Info |
| R-848 | An immune response modifier that acts as a ligand of TLR7 and 8; demonstra… | 50 mg | 14806-50 | More Info |
| R-8507 | An antagonist of TNF-αRI; inhibits ICAM-1 expression induced by TNF-… | 1 mg | 22479-1 | More Info |
| R-8507 | An antagonist of TNF-αRI; inhibits ICAM-1 expression induced by TNF-… | 10 mg | 22479-10 | More Info |
| R-8507 | An antagonist of TNF-αRI; inhibits ICAM-1 expression induced by TNF-… | 25 mg | 22479-25 | More Info |
| R-8507 | An antagonist of TNF-αRI; inhibits ICAM-1 expression induced by TNF-… | 5 mg | 22479-5 | More Info |
| R-6890 | An analytical reference standard categorized as an opioid; has analgesic e… | 1 mg | 39967-1 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile